Details for New Drug Application (NDA): 020151
✉ Email this page to a colleague
NDA 020151 describes EFFEXOR, which is a drug marketed by Wyeth Pharms Inc and Upjohn and is included in two NDAs. Additional details are available on the EFFEXOR profile page.
The generic ingredient in EFFEXOR is venlafaxine hydrochloride. There are seventy-one drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the venlafaxine hydrochloride profile page.
The generic ingredient in EFFEXOR is venlafaxine hydrochloride. There are seventy-one drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the venlafaxine hydrochloride profile page.
Summary for 020151
| Tradename: | EFFEXOR |
| Applicant: | Wyeth Pharms Inc |
| Ingredient: | venlafaxine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020151
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 28, 1993 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 28, 1993 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 28, 1993 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 020151
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Wyeth Pharms Inc | EFFEXOR | venlafaxine hydrochloride | TABLET;ORAL | 020151-006 | Dec 28, 1993 | 5,916,923 | ⤷ Get Started Free |
| Wyeth Pharms Inc | EFFEXOR | venlafaxine hydrochloride | TABLET;ORAL | 020151-003 | Dec 28, 1993 | 6,274,171 | ⤷ Get Started Free |
| Wyeth Pharms Inc | EFFEXOR | venlafaxine hydrochloride | TABLET;ORAL | 020151-004 | Dec 28, 1993 | 6,274,171 | ⤷ Get Started Free |
| Wyeth Pharms Inc | EFFEXOR | venlafaxine hydrochloride | TABLET;ORAL | 020151-003 | Dec 28, 1993 | 4,535,186*PED | ⤷ Get Started Free |
| Wyeth Pharms Inc | EFFEXOR | venlafaxine hydrochloride | TABLET;ORAL | 020151-005 | Dec 28, 1993 | 6,274,171 | ⤷ Get Started Free |
| Wyeth Pharms Inc | EFFEXOR | venlafaxine hydrochloride | TABLET;ORAL | 020151-001 | Dec 28, 1993 | 4,535,186*PED | ⤷ Get Started Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
